Multi-modality imaging recommendations for the diagnosis, family screening, follow-up, and risk assessment of arrhythmogenic cardiomyopathy are provided in this expert consensus document.
How should multi-modality imaging be used in the diagnosis, family screening, follow-up, risk assessment, and differential diagnosis of arrhythmogenic cardiomyopathy?
This expert consensus document provides standardized clinical recommendations for utilizing multi-modality imaging in the diagnosis, risk assessment, and follow-up of arrhythmogenic cardiomyopathy.
Arrhythmogenic cardiomyopathy (AC) is a progressive disease with high risk of life-threatening ventricular arrhythmias. A genetic mutation is found in up to 50-60% of probands, mostly affecting desmosomal genes. Diagnosis of AC is made by a combination of data from different modalities including imaging, electrocardiogram, Holter monitoring, family history, genetic testing, and tissue properties. Being a progressive cardiomyopathy, repeated cardiac imaging is needed in AC patients. Repeated imaging is important also for risk assessment of ventricular arrhythmias. This expert consensus document gives clinical recommendations for how to use multi-modality imaging in the different aspects of AC disease, including diagnosis, family screening, follow-up, risk assessment, and differential diagnosis.
Haugaa et al. (Wed,) conducted a review in Arrhythmogenic cardiomyopathy. Multi-modality imaging was evaluated. Multi-modality imaging recommendations for the diagnosis, family screening, follow-up, and risk assessment of arrhythmogenic cardiomyopathy are provided in this expert consensus document.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: